Novel Inflammatory Biomarkers in Cardiovascular Therapeutics.

Current medicinal chemistry

PubMedID: 25921646

Tsigkou V, Siasos G, Oikonomou E, Zaromitidou M, Latsios G, Deftereos S, Cleman MW, Vavuranakis M, Kokkou E, Limberi M, Dimitropoulos S, Marinaki S, Stefanadis C, Tousoulis D. Novel Inflammatory Biomarkers in Cardiovascular Therapeutics. Curr Med Chem. 2015;.
Inflammation has long been established as an important determinant of cardiovascular disease progression. Currently, medical history, clinical examination laboratory data and imaging tests are invaluable for the diagnosis, prognosis and disease monitoring. Novel inflammatory biomarkers are also used to better re-stratified patients in risk groups but their potential to guide treatment decisions and management of patients has not been extensively evaluated. Therefore in this review article we present the most recent data concerning the use of inflammatory biomarkers in cardiovascular therapeutics.